Certified by Founder Lodge
LoQus23 Therapeutics Ltd
United Kingdom - Cambridge, Cambridgeshire
START UP
1 Disclosed Funding Rounds $46,550,175
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 02 ,2024 | Series A | $46,550,175 |
SV Health Investors
Forbion
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
VieCure | $45,000,000 | (Oct 2, 2024)
DocJuris | $8,000,000 | (Oct 2, 2024)
Enlaye | $1,700,000 | (Oct 2, 2024)
Thread AI | $6,000,000 | (Oct 2, 2024)
Nusano | $115,000,000 | (Oct 2, 2024)
